A Panel of 12-lncRNA Signature Predicts Survival of Pancreatic Adenocarcinoma

Journal of Cancer - Australia
doi 10.7150/jca.27823
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Ivyspring International Publisher

Related search

A Panel of 13-miRNA Signature as a Potential Biomarker for Predicting Survival in Pancreatic Cancer

Oncotarget
Oncology
2016English

LncRNA Profile Study Reveals a Seven-lncRNA Signature Predicts the Prognosis of Patients With Colorectal Cancer

Biomarker Research
BiochemistryMolecular MedicineClinical Biochemistry
2020English

A PD-L2-based Immune Marker Signature Helps to Predict Survival in Resected Pancreatic Ductal Adenocarcinoma

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

Melanoma MicroRNA Signature Predicts Post-Recurrence Survival

Clinical Cancer Research
Cancer ResearchOncology
2010English

Overexpression of BUB1B, CCNA2, CDC20, and CDK1 in Tumor Tissues Predicts Poor Survival in Pancreatic Ductal Adenocarcinoma

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2019English

A 10-Gene Progenitor Cell Signature Predicts Poor Prognosis in Lung Adenocarcinoma

Annals of Thoracic Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2011English

A Seven-Gene Signature Predicts Overall Survival of Patients With Colorectal Cancer

Oncotarget
Oncology
2016English

The Impact of a History of Cancer on Pancreatic Ductal Adenocarcinoma Survival

United European Gastroenterology Journal
OncologyGastroenterology
2018English

Does Long-Term Survival Exist in Pancreatic Adenocarcinoma?

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy